Brain targeted delivery of paclitaxel using endogenous ligand

Muthu, 2009, Nanoparticles based on PLGA and its co-polymer: an overview, Asian J Pharm, 3, 266, 10.4103/0973-8398.59948 Allemann, 1999, Biodegradable nanoparticles of particles of poly(lactic acid) and poly(lactic-co-glycolic acid) for parenteral administration, 163 Lewis, 1990, Controlled release of bioactive agents from lactide/gylcolide polymers, vol. 4, 1 Abhilash, 2010, Potential applications of Nanoparticles, Int J Pharm Bio Sci, 1, 1 Mirakabad, 2014, PLGA-Based nanoparticles as cancer drug delivery systems, Asian Pac J Cancer Prev, 15, 517, 10.7314/APJCP.2014.15.2.517 Decuzzi, 2009, Intravascular delivery of particulate systems: does geometry really matter?, Pharm Res, 26, 235, 10.1007/s11095-008-9697-x Gu, 2008, Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers, Proc Nat Acad Sci, 105, 2586, 10.1073/pnas.0711714105 Illum, 2006, Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems ?, J Pharm Sci, 96, 479 Mistry, 2015, Nose-to-brain delivery: Investigation of the transport of nanoparticles with different surface characteristics and sizes in excised porcine olfactory epithelium, Mol Pharm, 12, 2755, 10.1021/acs.molpharmaceut.5b00088 Ping, 2013, Paclitaxel nano-delivery systems: a comprehensive review, J Nanomed Nanotech, 4, 1 Liang, 2010, Circumventing tumor resistance to chemotherapy by nanotechnology, Methods Mol Biol, 596, 467, 10.1007/978-1-60761-416-6_21 Lohcharoenkal, 2014, Protein Nanoparticles as drug delivery carriers for cancer therapy, BioMed Res Int, 1, 10.1155/2014/180549 Danhiera, 2012, PLGA-based nanoparticles: an overview of biomedical applications, J Contr Rel, 161, 505, 10.1016/j.jconrel.2012.01.043 McCall, 2013, PLGA Nanoparticles formed by single- or double-emulsion with vitamin ETPGS, J Vis Exp, 82, 1 Weperen, 2015, Enhanced blood to brain drug delivery, Innov Pharm Tech, 55 Grover, 2014, Blood-brain barrier permeation of glutathione-coated nanoparticle, SOJ Pharm PharmSci, 1, 1 Schulz, 2000, Glutathione, oxidative stress and neurodegeneration, Eur J Biochem, 267, 4904, 10.1046/j.1432-1327.2000.01595.x Fessi, 1989, Nanocapsule formation by interfacial polymer deposition following solvent displacement, Int J Pharm, 55, R1, 10.1016/0378-5173(89)90281-0 Govender, 1999, PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug, J Contr Rel, 57, 171, 10.1016/S0168-3659(98)00116-3 Santos, 2012, Polymeric nanoparticles loaded with the 3,5,3′-triiodothyroacetic acid (Triac), a thyroid hormone: factorial design, characterization, and release kinetics, Nanotech Sci App, 5, 37 Patel, 2013, Development and characterization of glutathione- conjugated albumin nanoparticles for improved brain delivery of hydrophilic fluorescent marker, Drug Del, 20, 1, 10.1155/2013/370938 Kafedjiiski, 2005, Synthesis and in vitro evaluation of a novel chitosan–glutathione conjugate, Pharm Res, 22, 1480, 10.1007/s11095-005-6248-6 Kocbek, 2007, Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody, J Cont Rel, 120, 18, 10.1016/j.jconrel.2007.03.012 Zhao, 2010, Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles, Int J Nanomed, 5, 669 Subedi, 2009, Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin, Euro J Pharm Sci, 37, 508, 10.1016/j.ejps.2009.04.008 Nobs, 2003, Surface modification of poly (lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods, Int J Pharm, 250, 327, 10.1016/S0378-5173(02)00542-2 Nobs, 2004, Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting, Eur J Pharm Biopharm, 58, 483, 10.1016/j.ejpb.2004.04.006 Mona, 2011, Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I, Drug Dev Ind Pharm, 37, 178, 10.3109/03639045.2010.502534 Lima, 2012, Characterization and evaluation of BNIPDaoct-loaded PLGA nanoparticles for visceral leishmaniasis: in vitro and in vivo studies, Nanomed, 1 Sharma, 2014, Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation, Biomed Res Int, 1 Seju, 2011, Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies, Acta Biomat, 7, 4169, 10.1016/j.actbio.2011.07.025 Abdelbary, 2013, Brain targeting of olanzapine via intranasal delivery of core–shell difunctional block copolymer mixed nanomicellar carriers: In vitro characterization, ex vivo estimation of nasal toxicity and in vivo biodistribution studies, Int J Pharm, 452, 300, 10.1016/j.ijpharm.2013.04.084 Patel, 2011, Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route, J Drug Targ, 19, 468, 10.3109/1061186X.2010.523787 Alam, 2012, Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study, Int J Nanomed, 7, 5705, 10.2147/IJN.S35329 Misra, 2006, Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan, AAPS Pharm Sci Tech, 7, E1 Sirisuth, 2012, In vitro in vivo correlation definitions and regulatory guidance, Int J Gen Drugs, 1 Wu, 2014, Pharmacokinetics, brain distribution, release and blood-brain barrier transport of shunaoxin pills, J Ethnopharmacol, 151, 1133, 10.1016/j.jep.2013.12.027 Clausen, 2002, The role of glutathione in the permeation enhancing effect of thiolated polymers, Pharm Res, 19, 602, 10.1023/A:1015345827091